Vanguard Fiduciary Trust
BNGO icon

Vanguard Fiduciary Trust’s Bionano Genomics BNGO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.3K Hold
51,578
– – ﹤0.01% 3841
2026
Q1 		$60.3K Buy
+51,578
New +$66.1K ﹤0.01% 3801

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Vanguard Fiduciary Trust's BNGO Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Bionano Genomics (BNGO) position steady in Q2 2026 at 51,578 shares worth $58.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

Vanguard Fiduciary Trust first reported a position in BNGO in Q1 2026 and has held it in 2 quarters since. The position peaked at $60.3K in Q1 2026. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Vanguard Fiduciary Trust held 51,578 shares of Bionano Genomics worth $58.3K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Bionano Genomics share count unchanged in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3841 holding.
  • Vanguard Fiduciary Trust first reported a position in Bionano Genomics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Bionano Genomics position peaked at $60.3K in Q1 2026.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.